Literature DB >> 6747307

Comparison of polyethylene glycols as fusogens for producing lymphocyte-myeloma hybrids.

R D Lane, R S Crissman, M F Lachman.   

Abstract

In order to improve the yield of hybridomas for monoclonal antibody production, 8 different sources and molecular weights of polyethylene glycol (PEG) were compared as fusing agents. Sp2/0 myeloma cells were fused with murine splenic lymphocytes immunized with sheep red blood cells. The Kodak 1450 PEG produced the maximum number of hybridomas. The optimal technique consisted of slowly adding 1 ml of freshly prepared fusogen (5 g Kodak 1450 PEG, 0.5 ml dimethylsulfoxide, and 5 ml of phosphate-buffered saline, pH 7.0) to the cells over a 1 min period, incubating the mixture at 37 degrees C for 90 s, then gradually diluting the mixture in 50 ml of Hanks' buffered salt solution. After 10 min, the cells are centrifuged, resuspended in selective medium with feeder macrophages and cultured. This procedure routinely produces between 600-3,000 hybridomas per fusion.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6747307     DOI: 10.1016/0022-1759(84)90434-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  9 in total

1.  Spatial and Temporal Deposition of Adhesive Extracellular Polysaccharide Capsule and Fimbriae by Hyphomonas Strain MHS-3.

Authors:  E J Quintero; K Busch; R M Weiner
Journal:  Appl Environ Microbiol       Date:  1998-04       Impact factor: 4.792

2.  Production and characterization of monoclonal antibodies specific for Cryptococcus neoformans capsular polysaccharide.

Authors:  T F Eckert; T R Kozel
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

3.  Functional and topographical analyses of epitopes on the hemagglutinin (VP4) of the simian rotavirus SA11.

Authors:  J W Burns; H B Greenberg; R D Shaw; M K Estes
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

Review 4.  Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies.

Authors:  Scott A Smith; James E Crowe
Journal:  Microbiol Spectr       Date:  2015-02

5.  Production and characterization of monoclonal antibodies specific for Shewanella colwelliana exopolysaccharide.

Authors:  D D Sledjeski; R M Weiner
Journal:  Appl Environ Microbiol       Date:  1993-05       Impact factor: 4.792

6.  Monoclonal antibodies reactive with immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans.

Authors:  Suzanne Brandt; Peter Thorkildson; Thomas R Kozel
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

7.  A der(8)t(8;11) chromosome in the Karpas-620 myeloma cell line expresses only cyclin D1: yet both cyclin D1 and MYC are repositioned in close proximity to the 3'IGH enhancer.

Authors:  Amel Dib; Oleg K Glebov; Yaping Shou; Robert H Singer; W Michael Kuehl
Journal:  DNA Repair (Amst)       Date:  2008-12-27

8.  Broad-spectrum inhibition of HIV-1 by a monoclonal antibody directed against a gp120-induced epitope of CD4.

Authors:  Samuele E Burastero; Barbara Frigerio; Lucia Lopalco; Francesca Sironi; Daniela Breda; Renato Longhi; Gabriella Scarlatti; Silvana Canevari; Mariangela Figini; Paolo Lusso
Journal:  PLoS One       Date:  2011-07-19       Impact factor: 3.240

Review 9.  Hybridoma technology: new developments of practical interest.

Authors:  S R Samoilovich; C B Dugan; A J Macario
Journal:  J Immunol Methods       Date:  1987-08-03       Impact factor: 2.303

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.